Back to Agenda
S22 : Modernizing Clinical Trials with Pragmatic Elements: Regulatory and Sponsor Perspectives from Japan and Beyond
Session Chair(s)
Harumasa Nakamura, MD, PhD
Director of Department of Clinical Research Support, , National Center of Neurology and Psychiatry, Japan
Speaker(s)
Mizuki Yoshida
Statistician, Pfizer R&D Japan, Japan
Fumie Yamazaki
Head of Development Japan, UCB Japan Co.,Ltd., Japan
Hironori Sakai
Director, Clinical Quality Head Quaters, Eisai Co., Ltd., Japan
Yuki Ando, PhD
Principal Senior Scientist for Biostatistics, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Have an account?